1. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1024,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1122KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
2. |
Modelling the cost-utility of breast cancer treatment |
|
Inpharma Weekly,
Volume &NA;,
Issue 1024,
1996,
Page 3-4
Jo Fitz-Gerald,
Preview
|
PDF (2107KB)
|
|
摘要:
The treatment of advanced breast cancer represents a substantial economic burden to healthcare systems. The need to justify spending in this area is clear, but the process is hampered by the limited number of measurable benefits in terms of traditional clinical endpoints, such as survival. Now, a new decision-analytic, computer-based model has been designed to evaluate the cost utility of the taxoids docetaxel and paclitaxel vs standard second-line therapy in women with recurrent metastatic breast cancer. The model, which views the data from a healthcare perspective, was presented at HealthEcon'96 [Health Economics & Outcomes Research in the Pharmaceutical Industry;London, UK; January 1996]. The conference was organised by IBC UK and Adis International.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
3. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1024,
1996,
Page 5-5
&NA;,
Preview
|
PDF (1032KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
4. |
Cost issues in diabetes mellitus |
|
Inpharma Weekly,
Volume &NA;,
Issue 1024,
1996,
Page 6-6
&NA;,
Preview
|
PDF (1060KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
5. |
Oral clarithromycin cuts the cost of treating pneumonia |
|
Inpharma Weekly,
Volume &NA;,
Issue 1024,
1996,
Page 7-7
Jill Stein,
Preview
|
PDF (1075KB)
|
|
摘要:
Three recent studies have shown that cost savings can be made by using the antibacterial clarithromycin to treat hospitalised patients with community-acquired pneumonia. The findings of these studies were presented at the 3rd International Conference on the Macrolides, Azalides and Streptogramins [Lisbon, Portugal; January 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
6. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1024,
1996,
Page 8-8
&NA;,
Preview
|
PDF (1074KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
7. |
Stroke studies lead to new era for thrombolytic therapy |
|
Inpharma Weekly,
Volume &NA;,
Issue 1024,
1996,
Page 9-10
Robert H Carlson,
Preview
|
PDF (2128KB)
|
|
摘要:
Thrombolytic therapy looks set to find a new niche as therapy for acute stroke as a recent trial confirms the value of using IV alteplase [t-PA; tissue plasminogen activator] in this indication. Thrombolytic agents, such as alteplase, have been approved for the treatment of myocardial infarction (MI) for many years, but it is only recently that attention has been drawn to their value in reducing acute stroke-related injury. In fact, 1995 was a banner year for trials of thrombolytic therapy in stroke, as shown by the number of presentations on this subject that were featured during the American Heart Association's 21st International Joint Conference on Stroke and Cerebral Circulation [San Antonio, Texas, US; January 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
8. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1024,
1996,
Page 10-10
&NA;,
Preview
|
PDF (1094KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
9. |
MBP analogue effective in experimental encephalomyelitis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1024,
1996,
Page 11-11
&NA;,
Preview
|
PDF (918KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
10. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1024,
1996,
Page 12-12
&NA;,
Preview
|
PDF (1097KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|